Conformational analysis of cholecystokinin CCK26-33 and related fragments by 1H NMR spectroscopy, fluorescence-transfer measurements, and calculations.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Biochemistry

• Publication date

  1986-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI00361A008PMID 3741836
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Determination of the intramolecular tyrosine-tryptophan distance in a 7-peptide related to the C-terminal sequence of cholecystokinin.

  2009cited by this paper
• Unique cholecystokinin peptides isolated from guinea pig intestine.

  1985cited by this paper
• Cholecystokinin Potentiation of Dopamine‐mediated Behaviors in the Nucleus Accumbens

  1985cited by this paper
• Differences in binding properties of mu and delta opioid receptor subtypes from rat brain: kinetic analysis and effects of ions and nucleotides.

  1985cited by this paper
• Conformational analysis of cholecystokinin fragments CCK4, CCK5, and CCK6 by 1H‐nmr spectroscopy and fluorescence‐transfer measurements

  1985cited by this paper
• Differences in Binding Properties of μ and δ Opioid Receptor Subtypes from Rat Brain: Kinetic Analysis and Effects of Ions and Nucleotides

  1985cited by this paper
• Conformational Analysis and Structural Activity Relationships of Cholecystokinin Peptides

  1985cited by this paper
• Pancreatic CCK receptors: characterization of covalently labeled subunits.

  1984cited by this paper
• Brain CCK receptors are structurally distinct from pancreas CCK receptors.

  1984cited by this paper
• Binding specificity of the mouse cerebral cortex receptor for small cholecystokinin peptides.

  1984cited by this paper
• 1H NMR conformational study of sulfated and non-sulfated cholecystokinin fragment CCK27-33: influence of the sulfate group on the peptide folding.

  1983cited by this paper
• Tritium-sensitive film autoradiography of [3H]cholecystokinin-5/pentagastrin receptors in rat brain.

  1983cited by this paper
• Solvent suppression in Fourier transform nuclear magnetic resonance

  1983cited by this paper
• Correlation of 15N and 13C relaxation data as a mobility probe for linear peptides. A theoretical and experimental study using enkephalins and related models

  1983cited by this paper
• Conformational dependence of the vicinal proton coupling constant for the CαCβ bond in peptides

  1982cited by this paper
• Multiple quantum filters for elucidating NMR coupling networks

  1982cited by this paper
• Proposals for conformation of enkephalins related to opiate mu-pharmacophore.

  1981cited by this paper
• Structural requirements for specific recognition of mu or delta opiate receptors.

  1981cited by this paper
• The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampus.

  1981cited by this paper
• Conformational studies of dansylated enkephalins by fluorescence transfer measurements, proton nuclear magnetic resonance spectroscopy, and theoretical calculations.

  1981cited by this paper
• Distinct cholecystokinin receptors in brain and pancreas.

  1980cited by this paper
• Demonstration of a putative receptor site for cholecystokinin in rat brain

  1980cited by this paper
• Release of cholecystokinin peptides from a synaptosome-enriched fraction of rat cerebral cortex.

  1979cited by this paper
• Analysis of the 1H‐NMR spectra of ferrichrome peptides. I. The non‐amide protons

  1978cited by this paper
• Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog.

  1978cited by this paper
• 1H NMR titration shifts of amide proton resonances in polypeptide chains

  1977cited by this paper
• Cholecystokinin (pancreozymin). 3. Synthesis and properties of an analogue of the C-terminal heptapeptide with serine sulfate replacing tyrosine sulfate.

  1977cited by this paper
• Effects of long range interactions on the conformational statistics of short polypeptide chains generated by a Monte Carlo method

  1977cited by this paper
• Immunochemical evidence of cholecystokinin-like peptides in brain

  1976cited by this paper
• Conformation of Met5-enkephalin determined by high field PMR spectroscopy

  1976cited by this paper
• Action of cholecystokinin and cholinergic agents on calcium transport in isolated pancreatic acinar cells.

  1975cited by this paper
• New peptide in the vertebrate CNS reacting with antigastrin antibodies

  1975cited by this paper
• Hormonal polypeptides of the upper intestine.

  1971cited by this paper
• Cholecystokinin-pancreozymin

  1970cited by this paper
• Intramolecular singlet excitation transfer. Applications to polypeptides.

  1969cited by this paper
• Fluorescence Quantum Yields of Tryptophan and Tyrosine

  1967cited by this paper
• Nuclear magnetic resonance study of some α-amino acids—II. Rotational isomerism

  1964cited by this paper
• Zwischenmolekulare Energiewanderung und Fluoreszenz

  1948cited by this paper
• A HORMONE MECHANISM FOR GALL-BLADDER CONTRACTION AND EVACUATION

  1928cited by this paper

• Tyrosine Sulfation Restricts the Conformational Ensemble of a Flexible Peptide, Strengthening the Binding Affinity for an Antibody.

  2018cites this paper
• Chapter 99 – CCK

  2013cites this paper
• Amphiphilic CCK peptides assembled in supramolecular aggregates: structural investigations and in vitro studies.

  2011cites this paper
• Update 1 of: Over one hundred peptide-activated G protein-coupled receptors recognize ligands with turn structure.

  2010cites this paper
• Synthesis of cyclic analogues of cholecystokinin highly selective for central receptors.

  2009cites this paper
• Computational molecular modeling in peptide drug design.

  2009cites this paper
• Computational analysis of conformational behavior of cholecystokinin fragments. I-CCK4, CCK5, CCK6 and CCK7 molecules.

  2009cites this paper
• Structure-conformation relationships of synthetic peptide inhibitors of human renin studied by resonance energy transfer and molecular modeling.

  2009cites this paper
• Cholecystokinin analogues with high affinity and selectivity for brain membrane receptors.

  2009cites this paper
• Solid phase synthesis of a fully active analogue of cholecystokinin using the acid-stable Boc-Phe (p-CH2) SO3H as a substitute for Boc-Tyr(SO3H) in CCK8.

  2009cites this paper
• Tyrosine modification enhances metal-ion binding.

  2008cites this paper
• Disulfide-containing peptides from the glandular skin secretions of froglets of the genus Crinia: structure, activity and evolutionary trends.

  2008cites this paper
• Biologically Active Peptides from

  2008cites this paper
• The micelle-associated 3D structures of Boc-Y(SO3)-Nle-G-W-Nle-D-2-phenylethylester (JMV-180) and CCK-8(s) share conformational elements of a calculated CCK1 receptor-bound model.

  2008influential citation
• Structure-activity relationships of bifunctional cyclic disulfide peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors.

  2008cites this paper
• Pharmacology of CCKRs and SAR studies of peptidic analog ligands.

  2007cites this paper
• CHAPTER 99 – CCK/Gastrin

  2006cites this paper
• Structural characterisation of the solution and membrane-associated conformations of human little gastrin and its bioactive fragments by NMR spectroscopy and molecular modelling

  2006cites this paper
• 24 Cholecystokinin Peptides in Brain Function

  2006cites this paper
• Conformationally constrained CCK4 analogues incorporating IBTM and BTD beta-turn mimetics.

  2005cites this paper
• Synthesis of Novel Biologically Active Peptide Analogues that are Agonists at Opioid Receptors and Antagonists at Cholecystokinin Receptors

  2005cites this paper
• Over one hundred peptide-activated G protein-coupled receptors recognize ligands with turn structure.

  2005cites this paper
• Measurement of intermolecular distances for the natural agonist Peptide docked at the cholecystokinin receptor expressed in situ using fluorescence resonance energy transfer.

  2004cites this paper
• The design and synthesis of novel beta-substituted amino acids, bicyclic dipeptide mimetics, and their incorporation into cholecystokinin/opioidchimeric peptides

  2004cites this paper
• New paradigm for drug design: Design and synthesis of novel biologically active peptides that are agonists at opioid receptors and antagonists at cholecystokinin receptors

  2003cites this paper
• Conformational and molecular modeling studies of sulfated cholecystokinin-15.

  2002cites this paper
• NMR evidence for different conformations of the bioactive region of rat CCK-8 and CCK-58.

  2002cites this paper
• Molecular basis of agonist binding to the type A cholecystokinin receptor.

  2002cites this paper
• NMR studies of CCK-8/CCK1 complex support membrane-associated pathway for ligand-receptor interaction.

  2002cites this paper
• Refinement of the conformation of a critical region of charge-charge interaction between cholecystokinin and its receptor.

  2002cites this paper
• Phenotypes of mice with invalidation of cholecystokinin (CCK(1) or CCK(2)) receptors.

  2002cites this paper
• Moleular models for cholecystokinin-A receptor.

  2002cites this paper
• NMR studies of CCK-8/CCK 1 complex support membrane-associated pathway for ligand-receptor

  2002cites this paper
• Resonance Energy Transfer

  2002cites this paper
• Computer modelling of new pseudopeptide CCK2 agonists

  2002cites this paper
• Characterization of the type A cholecystokinin receptor hormone-binding domain: use of contrasting and complementary methodologies.

  2001cites this paper
• Insights into peptide and protein function: a convergent approach 1 2

  2001cites this paper
• Insights into the Molecular Basis of Ligand Binding by the Cholecystokinin Receptor

  2001cites this paper
• Refinement of the Structure of the Ligand-occupied Cholecystokinin Receptor Using a Photolabile Amino-terminal Probe*

  2001cites this paper
• Peptide hormone binding to G‐protein‐coupled receptors: Structural characterization via NMR techniques

  2001cites this paper
• Chemoenzymatic synthesis of PSGL-1 glycopeptides: sulfation on tyrosine affects glycosyltransferase-catalyzed synthesis of the O-glycan.

  2000cites this paper
• Role of tyrosine sulfation and serine phosphorylation in the processing of procholecystokinin to amidated cholecystokinin and its secretion in transfected AtT-20 cells.

  2000cites this paper
• CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology.

  1999cites this paper
• International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors.

  1999cites this paper
• Identical primary sequence but different conformations of the bioactive regions of canine CCK-8 and CCK-58.

  1999cites this paper
• Modification of receptor selectivity and functional activity of cyclic cholecystokinin analogues

  1998cites this paper
• Targeting of a cholecystokinin–DNA complex to pancreatic cells in vitro and in vivo

  1998cites this paper
• Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.

  1997cites this paper
• Comparative Conformational Analysis of CCK‐B Agonist Boc‐Trp‐Phg‐Asp‐(1‐Nal)‐NH2 and CCK‐B Antagonist Boc‐Trp‐Phg‐Asp‐(1‐Nal)‐N(Me)2 Using 1H NMR Spectroscopy and Restrained Molecular Dynamics

  1996cites this paper
• Evidence that CCK-58 has structure that influences its biological activity.

  1996cites this paper
• Potential Bioactive Conformations of Hormones of the Gastrin Family

  1995cites this paper
• Opioid and CCK Systems in Anxiety and Reward

  1995cites this paper
• Optimization of Peptide Leads and Molecular Modeling

  1995cites this paper
• Synthesis of cyclic CCK analogs

  1995cites this paper
• RATIONAL DRUG DESIGN BASED ON TARGET STRUCTURE ANALOGIES AND MOLECULAR BIOLOGY STUDIES

  1995cites this paper
• Ac-[3- and 4-alkylthioproline31]-CCK4 analogs: synthesis and implications for the CCK-B receptor-bound conformation.

  1995cites this paper
• 6 – Structure–Function Studies of Peptide Hormones: An Overview

  1995cites this paper
• A Perspective of Peptide Modelling

  1994cites this paper
• Conformational analysis of CCK‐B agonists using 1H‐nmr and restrained molecular dynamics: Comparison of biologically active Boc‐Trp‐(N‐Me)Nle‐Asp‐Phe‐NH2 and inactive Boc‐Trp‐(N‐Me)Phe‐Asp‐Phe‐NH2

  1994cites this paper
• Protein tyrosine sulfation, 1993--an update.

  1994cites this paper
• Solution conformation of CCK9, a cholecystokinin analog.

  1993cites this paper
• Cholecystokinin peptidomimetics as selective CCK-B antagonists: design, synthesis, and in vitro and in vivo biochemical properties.

  1993cites this paper
• Models for the A- and B-receptor-bound conformations of CCK-8.

  1993cites this paper
• Tritium labelling of two highly selective agonists for CCK‐B receptor: [3H]propionyl‐Tyr(SO3Na)‐gNle‐mGly‐Trp‐(N‐Me)Nle‐Asp‐Phe‐NH2([3H]pBC 264) [3H]propionyl‐γDLys‐Trp‐Nle‐Asp‐Phe‐NH2([3H]pBC 254)

  1992cites this paper
• Analogs of Ac-CCK-7 incorporating dipeptide mimics in place of Met28-Gly29.

  1992cites this paper
• Induction and detection of anti-peptide antibody specificity is critically affected by the mode of hapten presentation.

  1992cites this paper
• [Study of induced effects by selective CCKB agonists cholecystokinin in the nociception and behavior in rodents].

  1992cites this paper
• Investigation of zinc‐binding affinities of moloney murine leukemia virus nucleocapsid protein and its related zinc finger and modified peptides

  1991cites this paper
• Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists.

  1990cites this paper
• Correlation Analysis and Molecular Modeling of Cholecystokinin Inhibitors

  1990cites this paper
• Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors.

  1990cites this paper
• Degradation of human gastrin and CCK by endopeptidase 24.11: differential behaviour of the sulphated and unsulphated peptides.

  1989cites this paper
• Delta opioid receptor selectivity induced by conformational constraints in linear enkephalin-related peptides: 1H 400-MHz NMR study and theoretical calculations.

  1989cites this paper
• A comparison of the antioxidant requirements of proteins with those of synthetic polymers suggests an antioxidant function for clusters of aromatic and bivalent sulphur-containing amino acid residues.

  1989cites this paper
• Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors.

  1989cites this paper
• Conformational behavior of cyclic CCK‐related peptides determined by 400‐MHz 1H‐nmr: Relationships with affinity and selectivity for brain receptors

  1989cites this paper
• Comparison of CCK-8 receptors in the pancreas and brain of rats using CCK-8 analogues.

  1989cites this paper
• Computer simulation of the conformational behavior of cholecystokinin fragments: Conformational families of sulfated CCK8

  1989cites this paper
• Electrophysiological studies with new CCK analogs: correlation with binding affinity on B-type receptors.

  1989cites this paper
• Cyclic cholecystokinin analogues with high selectivity for central receptors.

  1988cites this paper
• Secretin and cholecystokinin

  1988cites this paper
• Cyclic CCK-8 analogs highly selective for central receptors

  1988cites this paper
• Conformational analysis of possible biologically active (receptor-bound) conformations of peptides derived from cholecystokinin, cerulein and little gastrin and the opiate peptide, Met-enkephalin.

  1988cites this paper
• Neuropeptidergic Pathways as Possible Targets for the Development of New Therapeutic Agents

  1988cites this paper
• Synthesis and biological activity of CCK26-33-related analogues modified in position 31.

  1988cites this paper
• Investigation of peripheral cholecystokinin receptor heterogeneity by cyclic and related linear analogues of CCK26-33: synthesis and biological properties.

  1987cites this paper
• On the biologically active structures of cholecystokinin, little gastrin, and enkephalin in the gastrointestinal system.

  1987cites this paper
• ENKEPHALINASE, A METALLOENDOPEPTIDASE INVOLVED IN THE INACTIVATION OF BIOLOGICALLY ACTIVE PEPTIDES

  1987cites this paper
• Chapter 6 Neuropeptides and Their Processing: Targets for Drug Design

  1987cites this paper